Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,238 | 11,584 | 23,722 | 9,435 | N/A |
| Marketable Securities | 40,000 | 25,000 | 20,000 | 30,000 | N/A |
| Receivables | 787 | 508 | 299 | 538 | N/A |
| Other current assets | 0 | 276 | 94 | 0 | 0 |
| TOTAL | $82,485 | $38,100 | $44,771 | $40,624 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 35 | 37 | 38 | 38 | N/A |
| Investments And Advances | 75,000 | 0 | 0 | 0 | 0 |
| Intangibles | 1,764 | 1,813 | 1,861 | 895 | 0 |
| TOTAL | $76,799 | $1,850 | $1,899 | $933 | $N/A |
| Total Assets | $159,284 | $39,950 | $46,670 | $41,557 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,371 | 5,920 | 4,653 | 4,522 | 0 |
| TOTAL | $6,491 | $5,977 | $4,653 | $4,524 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 246,593 | 231,916 | 185,706 | 0 |
| TOTAL | $N/A | $246,593 | $231,916 | $185,706 | $N/A |
| Total Liabilities | $6,491 | $252,569 | $236,569 | $190,229 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 230,660 | 324 | 314 | 272 | N/A |
| Retained earnings | -79,823 | -214,104 | -190,780 | -149,443 | N/A |
| TOTAL | $152,793 | $-212,619 | $-189,899 | $-148,672 | $N/A |
| Total Liabilities And Equity | $159,284 | $39,950 | $46,670 | $41,557 | $0 |